XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and liabilities at Fair Value on Recurring Basis
Assets and liabilities carried at fair value on a recurring basis consisted of the following (in thousands):
September 30, 2025December 31, 2024
Fair ValueLevel 1Level 2Level 3Fair ValueLevel 1Level 2Level 3
Assets:
Assets held in rabbi trust$13,266 $— $13,266 $— $12,191 $— $12,191 $— 
Convertible notes$5,944 $— $— $5,944 $6,347 $— $— $6,347 
Cash equivalents (1):
       
Money market funds22,016 22,016 — — 90,737 90,737 — — 
$22,016 $22,016 $— $— $90,737 $90,737 $— $— 
Marketable debt securities, available-for-sale:        
Short-term investments:        
U.S. treasuries$11,930 $11,930 $— $— $29,517 $29,517 $— $— 
Corporate debt113,977 — 113,977 — 160,150 — 160,150 — 
ABS and other3,513 — 3,513 — — — — — 
$129,420 $11,930 $117,490 $— $189,667 $29,517 $160,150 $— 
Long-term investments:        
U.S. treasuries$29,197 $29,197 $— $— $773 $773 $— $— 
U.S. government sponsored entities2,811 — 2,811 — 929 — 929 — 
Corporate debt45,348 — 45,348 — 30,934 — 30,934 — 
ABS and other57,363 — 57,363 — 18,511 — 18,511 — 
$134,719 $29,197 $105,522 $— $51,147 $773 $50,374 $— 
Liabilities:        
Contingent consideration$1,148 $— $— $1,148 $4,731 $— $— $4,731 
Deferred consideration$— $— $— $— $411 $— $411 $— 
Deferred compensation liability$9,586 $9,586 $— $— $8,304 $8,304 $— $— 
(1)Included in cash, cash equivalents, and restricted cash on the accompanying condensed consolidated balance sheets.
Schedule of Reconciliation of Contingent Consideration Measured at Fair Value on Recurring Basis
A reconciliation of contingent consideration measured at fair value on a recurring basis consisted of the following (in thousands):
Nine Months Ended
September 30,
20252024
Beginning balance$4,731 $5,482 
Change in fair value of contingent consideration(1)
847 (364)
Payments of contingent consideration(4,430)— 
Ending balance$1,148 $5,118 
(1)Includes immaterial impact of foreign currency translation.
Schedule of Fair Value Liabilities Measured On Recurring Basis Valuation Techniques
Quantitative information about the valuation technique and significant unobservable inputs used in the valuation of the Company’s Level 3 financial liabilities measured at fair value on a recurring basis consisted of the following (dollars in thousands):
Fair Value at
September 30, 2025
Valuation TechniqueUnobservable inputs
Range (Weighted Average)(1)
Contingent
consideration
$1,148 Discounted cash flowExpected life of cash flows
0-2.1
 (0.8 years)
Discount rate
4.0%-5.4%
(4.8%)
Probability of achievement
0.0%-100.0%
(99.9%)
Fair Value at
December 31, 2024
Valuation TechniqueUnobservable inputs
Range (Weighted Average)(1)
Contingent
consideration
$4,731 Discounted cash flowExpected life of cash flows
0.3-2.8 years
 (0.4 years)
Discount rate
4.8%-6.1%
(5.9%)
Probability of achievement
0.0%-100.0%
(98.2%)
(1)Unobservable inputs were weighted by the relative fair value of the instruments.